Terence Kohler
Director of Finance/CFO at VERRICA PHARMACEUTICALS INC.
Net worth: 542 493 $ as of 2024-06-29
Profile
Terence Kohler is currently the Chief Financial Officer at Verrica Pharmaceuticals, Inc. Prior to this role, he served as the Treasurer & Vice President-Corporate Development at Endo International Plc from 2020 to 2021.
Mr. Kohler completed his undergraduate degree at Dickinson College and holds an MBA from The University of North Carolina at Chapel Hill and Kenan-Flagler Business School.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
2024-03-14 | 74,416 ( 0.18% ) | 542 493 $ | 2024-06-29 |
Terence Kohler active positions
Companies | Position | Start |
---|---|---|
VERRICA PHARMACEUTICALS INC. | Director of Finance/CFO | 2021-07-15 |
Former positions of Terence Kohler
Companies | Position | End |
---|---|---|
ENDO INTERNATIONAL PLC | Treasurer | 2021-06-30 |
Training of Terence Kohler
Dickinson College | Undergraduate Degree |
Kenan-Flagler Business School | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
VERRICA PHARMACEUTICALS INC. | Health Technology |
Private companies | 1 |
---|---|
Endo International Plc
Endo International Plc Pharmaceuticals: MajorHealth Technology Endo International Plc operates as a pharmaceutical company, which engages in the development, manufacture, and distribution of branded and generic pharmaceutical products. It operates through the following segments: Branded Pharmaceuticals, Sterile Injectables, Generic Pharmaceuticals and International Pharmaceuticals. The Branded Pharmaceuticals segment conducts certain operations in the U.S. through leased and owned manufacturing properties in Pennsylvania, New York and New Jersey, as well as certain administrative and R&D functions through leased properties in Pennsylvania. The Sterile Injectables segment includes manufacturing, quality assurance, research and development, and administration functions. The Generic Pharmaceuticals segment is composed of manufacturing, distribution, quality assurance and administration functions, as well as certain research and development functions. The International Pharmaceuticals segment’s operations are currently conducted through Paladin’s leased headquarters in Montreal, Canada. The company was founded in 1997 and is headquartered Dublin, Ireland. | Health Technology |
- Stock Market
- Insiders
- Terence Kohler